A multicenter, randomized, double-blind, parallel-group fixed-dose study of the effect on weight of befeprunox versus olanzapine in the treatment of outpatients with schizophrenia

Trial Profile

A multicenter, randomized, double-blind, parallel-group fixed-dose study of the effect on weight of befeprunox versus olanzapine in the treatment of outpatients with schizophrenia

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Jan 2008

At a glance

  • Drugs Bifeprunox; Olanzapine
  • Indications Schizophrenia
  • Focus Adverse reactions
  • Sponsors Wyeth
  • Most Recent Events

    • 22 Jan 2008 The expected completion date for this trial is now .
    • 26 Dec 2007 Status changed from in progress to completed according to ClinicalTrials.gov.
    • 10 Jul 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top